Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.

Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR.

Clin Gastroenterol Hepatol. 2011 Jan;9(1):64-70. doi: 10.1016/j.cgh.2010.08.019. Epub 2010 Sep 8.

2.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
3.

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.

Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.

Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.

PMID:
25203882
4.

Chronic viral hepatitis and hepatocellular carcinoma.

Barazani Y, Hiatt JR, Tong MJ, Busuttil RW.

World J Surg. 2007 Jun;31(6):1243-8.

PMID:
17440771
5.

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.

Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS.

Cancer. 2006 Nov 1;107(9):2212-22.

6.

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.

Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, Stanzione M, Durante-Mangoni E, Gentile I, Sagnelli E, Signoriello G, Miraglia Del Giudice E, Adinolfi LE, Coppola N.

Ann Hepatol. 2015 Jan-Feb;14(1):75-82.

7.

Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.

Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, Mettler TA, Giama NH, Roberts RO, Therneau TM, Petersen GM, Knutson KL, Roberts LR.

Mayo Clin Proc. 2012 Jan;87(1):17-24. doi: 10.1016/j.mayocp.2011.08.001.

8.

Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth.

Zampino R, Marrone A, Merola A, Trani B, Cirillo G, Karayiannis P, Coppola N, ZappalĂ  R, Utili R, Ruggiero G, Adinolfi LE.

J Med Virol. 2009 Dec;81(12):2012-20. doi: 10.1002/jmv.21560.

PMID:
19856471
9.
10.

Natural history of chronic hepatitis B and C.

Imperial JC.

J Gastroenterol Hepatol. 1999 May;14 Suppl:S1-5. Review.

PMID:
10382630
11.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
12.

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ, Su TH, Batrla-Utermann R, Chan HL, Kao JH, Chen CJ.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):461-468.e2. doi: 10.1016/j.cgh.2015.10.033. Epub 2015 Nov 18.

PMID:
26598229
13.

[Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival].

RodrĂ­guez-Vidigal FF, Baz MJ, Romero J, del Puerto M.

An Med Interna. 2005 Apr;22(4):162-6. Spanish.

PMID:
16004511
14.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
15.

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.

Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein C, Manns M.

Liver. 2000 Jul;20(4):312-8.

PMID:
10959810
16.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
17.

Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.

Hung CH, Chen CH, Lee CM, Hu TH, Lu SN, Wang JH, Huang CM.

Intervirology. 2013;56(5):316-24. doi: 10.1159/000350738. Epub 2013 Jul 2.

18.

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.

Cancer. 1997 Dec 1;80(11):2060-7.

PMID:
9392327
19.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
20.

The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.

Chiu HY, Chen CH, Wu MS, Cheng YP, Tsai TF.

Br J Dermatol. 2013 Dec;169(6):1295-303. doi: 10.1111/bjd.12461.

PMID:
23746170

Supplemental Content

Support Center